Clinical Site

Atlanta, Georgia 30338

1 studies enrolling now · 19 studies all time

What they study most

Acne Inversa, Bipolar Depression, Bipolar Disorder, Manic, Diabetes Mellitus, Type 2, Fatty Liver, Nonalcoholic, Generalized Anxiety Disorder, Hidradenitis Suppurativa, Hypertriglyceridemia, Major Depressive Disorder, Malignant Melanoma, Melanoma, NAFLD

Studies at this site

• Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• Study of Lumateperone in the Treatment of Patients With Bipolar Mania — Completed
• Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania — Completed
• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia — Completed
• Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder — Completed
• Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression — Completed
• An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• Study of a Novel Antipsychotic ITI-007 in Schizophrenia — Completed
• Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder — Completed
• Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) — Completed
• Lumateperone for the Prevention of Relapse in Patients With Schizophrenia — Completed
• Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression — Completed
• Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally — Completed
• Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease — Completed
• X4P-001 and Pembrolizumab in Patients With Advanced Melanoma — Completed
• A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma — Completed
• Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) — Completed
• Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) — Completed